Novo Nordisk A/S shareholders who purchased their securities between May 7, 2025, and July 28, 2025, are advised by Rosen Law Firm to consider legal action. With the lead plaintiff deadline set for September 30, 2025, investors are encouraged to act promptly to secure potential compensation.

The Rosen Law Firm has called upon investors of TechTarget, Inc. to inquire about a securities class action investigation concerning the company.

Investors who purchased American Depositary Shares of Reckitt Benckiser between January 13, 2021, and July 28, 2024, may have the opportunity to lead a securities fraud class action lawsuit. Rosen Law Firm has filed the suit, and the deadline to move the court to serve as lead plaintiff is August 4, 2025.